Evaluation of the Tasso-SST® capillary blood microsampling device for the measurement of endogenous uracil levels
Menestrina Dewes et al.
The finding, in our words
The LC-MS/MS assay for uracil was validated with good accuracy and precision, and uracil concentrations measured in Tasso-SST capillary serum correlated highly with venous plasma (rs 0.910), indicating that capillary microsampling can reliably identify patients with DPD deficiency for safer fluoropyrimidine dosing.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
The True Dose TD-EPI kit demonstrated strong analytical agreement with venous blood for epirubicin monitoring, and the capillary samples remained stable for 72 hours at ambient temperature.
Capillary blood sampling showed near-perfect correlation with venous sampling for total PSA across a wide clinical range with negligible bias, and samples remained stable at ambient temperature for up to eight days, supporting feasibility of home self-testing for prostate cancer.
Capillary blood collected with the Mitra® device showed correlation with venous samples for paclitaxel therapeutic drug monitoring, but wide confidence intervals suggest the methods may not be interchangeable. While plasma and whole blood concentrations were more closely aligned, the variability raises questions about using self-collected capillary samples for dose individualisation without further validation.
In AML and CLL, 91% of VAMS venetoclax results fell within 20% of plasma after individualised haematocrit correction; in home sampling, 18 of 21 patients self-sampled independently and 76% of returned samples were analysable, which shows home microsampling is workable, though the authors ask for multicentre validation.
The homeRNA capillary blood collection and stabilization platform successfully captured lipopolysaccharide-induced inflammatory gene expression profiles. These transcriptomic responses were comparable to those obtained from traditional venous blood samples stabilized with RNAlater or PAXgene, demonstrating the platform's suitability for remote transcriptomic monitoring.